circSLC30A7 Inhibits Hepatocellular Carcinoma Cell Proliferation via the miR-767-5p/FBXW7/NOTCH1 Axis

Figure 1

Expression and circRNA characterization of circSLC30A7 in HCC. (a) Sanger sequencing was conducted to confirm head-to-tail splicing. (b) CircSLC30A7 expression in HCC tissues (n = 50) and matched normal tissues (n = 50) was measured by qRT-PCR. (c) CircSLC30A7 expression in HCC cell lines was detected using qRT-PCR. (d) CircSLC30A7 and SLC30A7 levels were determined after actinomycin D stimulation. (e) CircSLC30A7 and SCL30A7 expression were examined in Huh7 and HepG2 cells exposed to RNase R. (f) CircSLC30A7 was predominantly localized in the cytoplasm by qRT-PCR analysis of cell fractions. (g) CircSLC30A7 was predominantly localized in the cytoplasm by FISH. , , .

(a)

(b)

(c)

(d)

(e)

(f)

(g)